H.R. 1843 (119th)Political Perspectives

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Mar 5, 2025
Discussions
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Loading perspective analysis...